Figure 4From: Salivary gland derived peptides as a new class of anti-inflammatory agents: review of preclinical pharmacology of C-terminal peptides of SMR1 proteinfeG and cardiovascular anaphylaxis: Anaphylaxis induced by ovalbumin (OA) challenge in previously sensitized rats causes rapid reduction in blood pressure (control). feG treatment orally at the time of OA challenge dose-dependently inhibited anaphylaxis-induced hypotension. (mean ± sem, n = 5 to 6). Adapted from [38].Back to article page